BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3203971)

  • 1. The fate of leached di-(2-ethylhexyl)-phthalate (DEHP) in patients on chronic haemodialysis.
    Flaminio LM; Bergia R; De Angelis L; Ferazza M; Marinovich M; Galli G; Galli CL
    Int J Artif Organs; 1988 Nov; 11(6):428-34. PubMed ID: 3203971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the leachability of di(2-ethylhexyl) phthalate and tri(2-ethylhexyl) trimellitate from haemodialysis tubing.
    Kambia K; Dine T; Azar R; Gressier B; Luyckx M; Brunet C
    Int J Pharm; 2001 Oct; 229(1-2):139-46. PubMed ID: 11604266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis.
    Pollack GM; Buchanan JF; Slaughter RL; Kohli RK; Shen DD
    Toxicol Appl Pharmacol; 1985 Jun; 79(2):257-67. PubMed ID: 4002227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leachability of a new plasticizer tri-(2-ethylhexyl)-trimellitate from haemodialysis tubing.
    Flaminio LM; De Angelis L; Ferazza M; Marinovich M; Galli G; Galli CL
    Int J Artif Organs; 1988 Nov; 11(6):435-9. PubMed ID: 2904924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uraemic pruritus and exposure to di(2-ethylhexyl) phthalate (DEHP) in haemodialysis patients.
    Mettang T; Thomas S; Kiefer T; Fischer FP; Kuhlmann U; Wodarz R; Rettenmeier AW
    Nephrol Dial Transplant; 1996 Dec; 11(12):2439-43. PubMed ID: 9017619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(2-ethylhexyl)phthalate concentrations in the serum of hemodialysis patients.
    Lewis LM; Flechtner TW; Kerkay J; Pearson KH; Nakamoto S
    Clin Chem; 1978 May; 24(5):741-6. PubMed ID: 647906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis.
    Nässberger L; Arbin A; Ostelius J
    Nephron; 1987; 45(4):286-90. PubMed ID: 3587468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis.
    Gibson TP; Briggs WA; Boone BJ
    J Lab Clin Med; 1976 Mar; 87(3):519-24. PubMed ID: 1249479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of plasticiser from haemodialysis blood tubing.
    Ono K; Ikeda T; Fukumitsu T; Tatsukawa R; Wakimoto T
    Proc Eur Dial Transplant Assoc; 1976; 12():571-6. PubMed ID: 935139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure of hemodialysis patients to di-2-ethylhexyl phthalate.
    Faouzi MA; Dine T; Gressier B; Kambia K; Luyckx M; Pagniez D; Brunet C; Cazin M; Belabed A; Cazin JC
    Int J Pharm; 1999 Mar; 180(1):113-21. PubMed ID: 10089298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacokinetic interpretation of increasing concentrations of DEHP in haemodialysed patients.
    Dine T; Luyckx M; Gressier B; Brunet C; Souhait J; Nogarede S; Vanpoucke J; Courbon F; Plusquellec Y; Houin G
    Med Eng Phys; 2000 Apr; 22(3):157-65. PubMed ID: 10964036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of leached di(2-ethylhexyl)phthalate in patients undergoing CAPD treatment.
    Mettang T; Thomas S; Kiefer T; Fischer FP; Kuhlmann U; Wodarz R; Rettenmeier AW
    Perit Dial Int; 1996; 16(1):58-62. PubMed ID: 8616175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP.
    Koch HM; Bolt HM; Angerer J
    Arch Toxicol; 2004 Mar; 78(3):123-30. PubMed ID: 14576974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid chromatographic analysis of di(2-ethylhexyl) phthalate: application to pharmacokinetic studies in the mongrel dog.
    Haughey DB; Elmquist WF; Breutzmann DA; Hemphill DG; Constantini EG
    Pharm Res; 1988 Jan; 5(1):10-5. PubMed ID: 3244602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diethylhexyl phthalate as a factor in blood transfusion and haemodialysis.
    Baker RW
    Toxicology; 1978 Apr; 9(4):319-29. PubMed ID: 351859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis(2-ethylhexyl) phthalate levels in nonuremic patients treated with extracorporeal devices.
    Chen WS; Kerkay J; Pearson KH; Paganini EP; Chang K; Steck WD; Becker JM; Bailin PL; Nakamoto S
    Proc Clin Dial Transplant Forum; 1979; 9():189-93. PubMed ID: 552041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phthalic acid is the main metabolite of the plasticizer di(2-ethylhexyl) phthalate in peritoneal dialysis patients.
    Mettang T; Alscher DM; Pauli-Magnus C; Dunst R; Kuhlmann U; Rettenmeier AW
    Adv Perit Dial; 1999; 15():229-33. PubMed ID: 10682108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradation of phthalate esters during the mesophilic anaerobic digestion of sludge.
    Gavala HN; Alatriste-Mondragon F; Iranpour R; Ahring BK
    Chemosphere; 2003 Jul; 52(4):673-82. PubMed ID: 12738281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic phthalate exposure on the kidney.
    Crocker JF; Safe SH; Acott P
    J Toxicol Environ Health; 1988; 23(4):433-44. PubMed ID: 3361614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
    Koch HM; Bolt HM; Preuss R; Angerer J
    Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.